Valuation : Telix Pharmaceuticals Limited

Market Cap 5.22B 3.74B 3.22B 3.02B 2.76B 5.18B 356B 35.81B 13.93B 180B 14.03B 13.73B 597B P/E 2026 *
234x
P/E 2027 * 159x
Enterprise Value 5.65B 4.05B 3.48B 3.27B 2.99B 5.61B 385B 38.75B 15.08B 195B 15.19B 14.86B 646B EV / Sales 2026 *
4.12x
EV / Sales 2027 * 3.63x
Free-Float
83.1%
Yield 2026 *
-
Yield 2027 * -
1 day-1.85%
1 week-1.66%
Current month+8.09%
1 month+9.17%
3 months+17.88%
6 months+57.38%
Current year+37.14%
1 week 15.17
Extreme 15.17
16.52
1 month 13.95
Extreme 13.95
18.13
Current year 8.26
Extreme 8.26
18.13
1 year 8.26
Extreme 8.26
18.32
3 years 8.2
Extreme 8.2
31.97
5 years 3.55
Extreme 3.55
31.97
10 years 0.46
Extreme 0.46
31.97
Manager TitleAgeSince
Chief Executive Officer 51 03/01/2017
Director of Finance/CFO 61 31/07/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 51 03/01/2017
Chairman 66 03/02/2026
Director/Board Member 68 19/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/26 A Free

Director

21,597 0.0064%
5/26/26 A Free

Founder

339,845 0.1001%
5/26/26 A Free

Director

21,597 0.0064%
Change 5-day change 1-year change 3-year change Capi.($)
-1.85%-1.66%+5.21%+39.13% 3.82B
-1.23%-1.91%+0.98%+17.94% 50.47B
-1.53%-3.37%+417.19%+501.84% 44.56B
-0.17%+0.17%+41.87%+17.09% 43.08B
-2.03%-3.61%+7.98%+72.75% 41.7B
-0.94%-1.77%+18.34%+46.84% 33.21B
-1.14%-4.69%+24.85%+118.66% 16.77B
+6.39%+5.00% - - 16.28B
+0.25%-0.98%+11.63%+27.62% 14.58B
-0.97%-4.77%+76.33%+37.48% 13.92B
Average -0.28%-1.10%+67.15%+97.71% 27.84B
Weighted average by Cap. -0.58%-1.03%+87.96%+120.77%

Financials

2026 *2027 *
Net sales 1.37B 982M 845M 794M 724M 1.36B 93.39B 9.4B 3.66B 47.36B 3.69B 3.61B 157B 1.58B 1.13B 972M 913M 833M 1.57B 107B 10.82B 4.21B 54.48B 4.24B 4.15B 180B
Net income 25.05M 17.94M 15.45M 14.5M 13.24M 24.87M 1.71B 172M 66.87M 866M 67.36M 65.9M 2.87B 19.91M 14.26M 12.28M 11.53M 10.52M 19.77M 1.36B 137M 53.15M 688M 53.54M 52.38M 2.28B
Net Debt 429M 307M 265M 248M 227M 426M 29.24B 2.94B 1.15B 14.83B 1.15B 1.13B 49.09B 498M 356M 307M 288M 263M 494M 33.91B 3.41B 1.33B 17.2B 1.34B 1.31B 56.94B
Logo Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Employees
1,152
Date Price Change Volume
31/08/26 A$15.36 -1.85% 1,092,733
28/08/26 A$15.65 +0.45% 985,671
27/08/26 A$15.58 +0.58% 1,273,984
26/08/26 A$15.49 -4.15% 1,504,493
25/08/26 A$16.16 0.00% 995,818
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
15.36AUD
Average target price
23.44AUD
Spread / Average Target
+52.58%

Quarterly revenue - Rate of surprise